Fennec Pharmaceuticals Inc. (FENC)
Fennec Pharmaceuticals Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Fennec Pharmaceuticals Inc. (FENC) is a Biotechnology company based in US with a market capitalization of $296.9M. Revenue declined 6.1% year-over-year and free cash flow was negative at -$12.5M. This page tracks FENC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 32 employees · IPO Sep 15, 2017
Valuation
Valuation & price
$9.75as of May 17, 2026· -12.6% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
8.47
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$296.9M
Market cap
-6.1%
Revenue growth (YoY)
91.6%
Gross margin
-$12.5M
Free cash flow (USD)
-$36.7M
Net debt
Net cash position
4.7%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2022 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
3
Insider sells · 90 days
Earnings
Last reported: May 14, 2026 (EPS $0.01)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJun 10, 2026Filing
Annual Meeting Results
- Insider sellJun 2, 2026Filing
Insider Sell $94K · 10b5-1 PlanRaykov Rosty · Director · $93.8K
- 8-K eventMay 22, 2026Filing
Research Presentation at ASCO
- 8-K eventMay 18, 2026Filing
Stock Option Grants
- Quarterly reportMay 14, 2026Filing
10-Q Filed
- Insider sellMay 12, 2026Filing
Insider Sell $59K · 10b5-1 PlanRALLIS CHRIS A · Director · $58.8K
- Insider sellMay 1, 2026Filing
Insider Sell $70K · 10b5-1 PlanRaykov Rosty · Director · $69.8K
- 8-K eventApr 28, 2026Filing
Director Retirement
- 8-K eventApr 22, 2026Filing
Abstracts Accepted for ASCO
- 8-K eventApr 7, 2026Filing
Investigator-Sponsored Study Initiated
Questions
Frequently asked questions
What is Fennec Pharmaceuticals Inc.'s market cap?
Fennec Pharmaceuticals Inc. (FENC) has a market capitalization of $296.9M.
What is FENC's P/E ratio?
A meaningful P/E ratio is not available for FENC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is FENC's price-to-book (P/B) ratio?
FENC trades at 8.47 times book value per share.
When did Fennec Pharmaceuticals Inc. last report earnings?
FENC last reported earnings on May 14, 2026; the next date is not yet scheduled.
Are insiders buying FENC stock?
SEC Form 4 filings show no open-market insider buys at Fennec Pharmaceuticals Inc. in the last 90 days (3 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.